Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
FINDEX Inc. ( (JP:3649) ) has shared an announcement.
FINDEX Inc. reported its preliminary results for product implementations as of December 31, 2024. The results highlight growth in user numbers across various medical software products, with significant increases noted for the Claio and DocuMaker software. This indicates a steady expansion in their market presence, particularly within university and general hospitals, potentially enhancing their industry positioning and stakeholder value.
More about FINDEX Inc.
FINDEX Inc. operates in the software industry, focusing on developing data management and document management software solutions. Its primary products include Claio, DocuMaker, C-Scan, PDI+ MoveBy, MapleNote, and REMORA, which are tailored for medical institutions such as hospitals and clinics, as well as solutions for local governments.
YTD Price Performance: 2.45%
Average Trading Volume: 41,089
Technical Sentiment Consensus Rating: Sell
Current Market Cap: Yen22.46B
For an in-depth examination of 3649 stock, go to TipRanks’ Stock Analysis page.